Immix Biopharma Inc <IMMX.O>: Needham initiates coverage with Buy rating; target price $21
IMMX•Related News
Juniata Valley Financial Q2 FY26 net income rises 32% to $2.5 million; EPS climbs 31.6% to $0.5
JUVF•
Elanco Animal Health Inc <ELAN.N>: Morgan Stanley raises target price to $26.00 from $23.00
ELAN•
Axcelis updates financial calendar for upcoming quarterly results release and conference call
ACLS•
Juniata Valley Q2 profit rises 32% on loan growth, higher interest income
JUVF•
Johnson & Johnson Innovation to host virtual pitch session for oral peptide delivery challenge finalists
JNJ•